Safety and Immunogenicity of Monovalent Omicron KP.2-Adapted BNT162b2 COVID-19 Vaccine in Adults: Single-Arm Substudy from a Phase 2/3 Trial. - Diya, Oyeniyi; Gayed, Juleen; Lowry, Francine S.; Ma, Hua; Bangad, Vishva; Mensa, Federico; Zou, Jing; Xie, Xuping; Hu, Yanping; Cutler, Mark; Belanger, Todd; Cooper, David; et al. (Infectious Diseases & Therapy, 2025)